Company · Healthcare · Robotics
Every investor coverage indicates participated in a round Remedy Robotics raised.
Companies Remedy Robotics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Remedy Robotics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Bioshore Ventures has wrapped up its first fund at $27 million with all capital committed, drawing 65 individual backers including three well-known investors, and has named four health-technology companies in its portfolio.
Blackbird interviews Remedy Robotics co-founder Dave Bell about his move from medicine to surgical robotics and his mentoring in its Foundry program, noting Foundry applications are open.